Effects of recombinant human growth hormone on enterocutaneous fistula patients

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 44

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Nov 28, 2008; 14(44): 6858-6862
Published online Nov 28, 2008. doi: 10.3748/wjg.14.6858

Table 1 General state of the patients

Age (Yr)	Sex	Weight (kg)	Distance from ligament of tretiz (cm)	Rest energy expenditure (KJ)	Enteral nutrition energy (KJ)
65	F	52	40	4276	6276
42	M	68	80	5648	8368
30	M	80	100	6192	9205
32	M	61	120	4384	6276
18	M	48	60	4322	6276
72	F	56	90	5773	8368
38	M	77	135	6158	9205
27	F	49	85	4359	6276

Citation: Gu GS, Ren JA, Li N, Li JS. Effects of recombinant human growth hormone on enterocutaneous fistula patients. World J Gastroenterol 2008; 14(44): 6858-6862
URL: https://www.wjgnet.com/1007-9327/full/v14/i44/6858.htm
DOI: https://dx.doi.org/10.3748/wjg.14.6858

Gu GS, Ren JA, Li N, Li JS. Effects of recombinant human growth hormone on enterocutaneous fistula patients. World J Gastroenterol 2008; 14(44): 6858-6862 [PMID: 19058314 DOI: 10.3748/wjg.14.6858]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.